Blood cell therapy

PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation.

Pub Date : 2025-05-25 DOI: 10.31547/bct-2024-034 Ling Ma, Si-Qi Li, Wei Han, Hai-Xia Fu, Yao Chen, Rui Ma, Yu-Hong Chen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Feng-Rong Wang, Xiao-Dong Mo, Xiao-Jun Huang, Yu-Qian Sun

Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias.

Pub Date : 2025-05-25 DOI: 10.31547/bct-2024-029 Sachin Punatar, Komal Kumbhalwar, Siddhesh A Kalantri, Anant Gokarn, Lingaraj Nayak, Akanksha Chichra, Sumeet Mirgh, Nishant Jindal, Libin Mathew, Sadhana Kannan, Navin Khattry

PYODERMA GANGRENOSUM WITH NON-PSEUDOMONAL ECTHYMA GANGRENOSUM IN MYELODYSPLASTIC SYNDROME TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

Pub Date : 2025-05-09 DOI: 10.31547/bct-2024-028 Christine Faith V Tan, Lynn B Bonifacio, Minette Claire O Rosario, Adolfo C Parayno